SOURCE: The Medicines Company
PARSIPPANY, NJ--(Marketwire - Mar 8, 2013) - The Medicines Company (NASDAQ: MDCO) has scheduled a conference call and webcast following release of the Phase 3 cangrelor CHAMPION PHOENIX trial results on Sunday, March 10, 2013 at 11:00 a.m. Pacific Time, 2:00 p.m. Eastern Time. MDCO management and experts are scheduled to discuss cangrelor trial results and outlook.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 866 700.6067
International Dial In: 617 213.8834
Passcode for both dial in numbers: 54431050
Replay is available from 4:00 p.m. Eastern Time following the conference call through March 17, 2013. To hear a replay of the call, dial 888 286.8010 (domestic) and 617 801.6888 (international). Passcode for both dial in numbers is 17733784.
This call is being webcast and can be accessed at The Medicines Company website at www.themedicinescompany.com.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is www.themedicinescompany.com.